Medicine and Dentistry
Patient
100%
Breast Cancer
63%
Malignant Neoplasm
62%
Health Care Cost
60%
Therapeutic Procedure
54%
Analysis
31%
Inpatient
27%
Cost-Effectiveness Analysis
26%
Randomized Controlled Trial
25%
Colorectal Cancer
22%
Health
22%
Age
19%
Woman
18%
Neoplasm
18%
Arm
17%
Mortality
17%
Chemotherapy
17%
Evaluation Study
17%
Symptomatic Treatment
16%
Surgery
15%
Cardiotoxicity
13%
Recurrent Disease
12%
Gene Linkage
12%
COVID-19
12%
Estrogen Receptor
12%
Lung Cancer
11%
Cancer Survival
11%
Anthracycline
11%
Cancer Incidence
10%
Quality Adjusted Life Year
10%
Adult
10%
Trastuzumab
10%
Bevacizumab
10%
Severe Acute Respiratory Syndrome Coronavirus 2
10%
Analgesia
10%
Sepsis
10%
Association
10%
Chemotherapy
9%
Survival
9%
Combination Therapy
9%
Toxicity
9%
Cancer Therapy
9%
Diagnosis
9%
Cancer Registry
8%
Oncology
8%
Fluid Resuscitation
8%
Comorbidity
8%
Cardiac Troponin
7%
Infection
7%
Triple Negative Breast Cancer
7%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
35%
Chemotherapy
35%
Malignant Neoplasm
22%
Trastuzumab
15%
Cardiotoxicity
13%
Clinical Trial
12%
Mortality
12%
Triple Negative Breast Cancer
12%
Placebo
10%
Toxicity
9%
Troponin
7%
Cohort Study
6%
Disease Free Survival
6%
Comorbidity
6%
Anthracycline
6%
Recurrent Disease
5%
Immunotherapy
5%
Modified Release
5%
Prevalence
5%
Paclitaxel
5%
Dyspnea
5%
Bevacizumab
5%
Morphine
5%
Malignant Neoplasm
5%
Capivasertib
5%
SARS Coronavirus
5%
Noninferiority Trial
5%
Frailty
5%
Cross-Sectional Study
5%
Drug Development
5%
Colon Cancer
5%
Nursing and Health Professions
Patient
29%
Malignant Neoplasm
19%
Colorectal Cancer
16%
Health Economics
15%
Chemotherapy
12%
Analysis
10%
Breast Cancer
10%
Measurement
6%
Cancer Therapy
6%
Cost Effectiveness Analysis
5%
Comorbidity
5%
Systematic Review
5%
Standard
5%
Resuscitation
5%
Sepsis
5%
Diagnostic Accuracy
5%
Biomedical Technology Assessment
5%
Albumin
5%
Pain Assessment
5%
Dyspnea
5%
Cohort Analysis
5%
Cancer Pain
5%
Morphine
5%
Troponin I
5%
Anthracycline
5%
Drug Development
5%
Placebo
5%
Palliative Therapy
5%
Analgesia
5%
Delirium
5%